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INTRODUCTION 
Cerebrovascular accident is an important cause of 
premature mortality and disability in developing coun-
tries like India [1]. In the USA stroke is the third most 
common cause of mortality and morbidity after cardio-
vascular disease and cancer[2] . Intracranial atheroscle-
rosis of large vessels is most common cause of cerebro-
vascular accident in India [3]. 
Stroke has occurred if the neurologic manifestations 
last for >24 hours or brain infarction is demonstrated 
on imaging study [4]. Extensive experimental evidence, 
both in vitro and in vivo, indicates that homocysteine 
causes endothelial dysfunction. Homocysteine changes 
vascular tone by regulating endothelium-dependent 
vasodilator and constrictor substances, including de-
creasing nitric oxide bioavailability, increasing contrac-
tile prostanoids as well as interfering myoendothelial 
communication [5]. 
For healthy middle aged adult individuals, hyperhomo-
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cysteinemia is an independent risk factor for endotheli-
al dysfunction [6].  Elevated homocysteine level is com-
mon and this is the major prothrombotic factor associ-
ated with stroke.   
Aims and objectives: To study serum homocysteine 
levels in cerebrovascular accident as a risk factor for 
stroke. 
MATERIAL AND METHODS 
Study design: The present case control analytical study 
Ethics approval: Study was approved by the Institution-
al ethics committee and informed consent was taken 
from the participants or from the blood relatives.  
Study location: BLDE University’s Shri B.M.Patil Medical 
College and Research Centre, Vijayapur. 
Study period: January 2016 to June 2017. 
Sample size: Total hundred and eighty were recruited 
for this study   
Inclusion criteria: 90 patients of stroke diagnosed by 
clinical examination and confirmed by CT scan and MRI 
brain, admitted in our hospital were included as study 
group and for control group age & sex matched healthy 
control were included in this study. 
Exclusion criteria:  Patients with the following concom-
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itant illnesses like - previous history of ischemic or val-
vular heart disease, past history of stroke, peripheral 
vascular disease, hypothyroidism, epilepsy, renal im-
pairment, drugs that affect homocysteine, Vit B12, Fo-
late metabolism i.e. fibrates, statins and niacin, metho-
trexate and sulfasalazine, anticonvulsant drugs, and 
levodopa, oral contraceptives, pregnancy, anticoagu-
lant therapy and anticoagulant therapy were known to 
elevate serum homocysteine were excluded from the 
study. 
Grouping: Grouped as Control and Study group 
Sample collection: 3ml fasting blood sample of 90 cas-
es and 90 control patients collected on admission. 
Methodology: Estimation of serum homocysteine level 
by Chemiluminescent Immunofluroscent Assay by In-
strument Minividas. The AMS enzymatic test for the 
quantitative homocysteine determination based on a 
series of enzymatic reaction causing a decrease in ab-
sorbance value due to NADH oxidation to NAD+. Homo-
cysteine concentration in sample is directly proposi-
tional to the quantity of NADH converted to NAD+.  
Statistical analysis: Data is presented diagrammatically 
and as mean ± SD. Groups are compared using  't' test, 
chi square test and  regression analysis  done.  
RESULTS 
According to this study only 1.1 % of patients is of 30-
39 years age group and 27.8 % of patients is of 70-79 
years age group. In this study 66.7 % patients are male 
and 33.3% patients are female. 
In study group the mean serum homocysteine level is 
31.47±39.89 µmol/L and in control group 16.62±22.08 
µmol/L, it indicates that serum homocysteine level is 
highly significantly raised in cases of stroke compared 
with control patients. 
The above results indicates that association between 
serum homocysteine level with age, sex and diagnosis 
were insignificant, but there is a significant correlation 
between serum homocysteine level and Diabetes Melli-
tus, hypertension,  
DISCUSSION 
 In this case control study we found a strong co-relation 
of hyperhomocysteinemia with ischemic stroke in both 
younger and older age group. The result of the present 
study are consistent with many case control and pro-
spective studies, although few prospective studies 
failed to establish correlation [7]. 
There is no definite threshold level for homocysteine 
that correlates with the sudden increase in the risk of 
vascular events. Although the normal range for homo-
cysteine level has been proposed to lie between 5 and 
15µmol/L, increased risk of vascular disease within this 
range is documented by Modiet al [7]. 
Many studies have showed that increased homocyste-
ine represents anindependent risk factor for coronary, 
cerebrovascular and peripheral arterial diseases[8],[9],
[10].Various risk factors for cerebrovascular accidents 
like age, sex, food habit, hypertension, diabetes melli-
tus and lifestyle were studied and analyzed in relation 
to serum homocysteine levels. 
Hyperhomocysteinemia is one of the newly recognized 
factor that increases the risk of vascular disease [11].  
Mechanisms by which hyperhomocysteinemia increas-
es risk of cerebrovascular accidents are not clear, but 
Parameter 
No. Of Pa-
tients 
Homocysteine level Mean ±SD 
(µmol/L) 
Mann Whitney U 
test 
Group 
Control 90 16.62±22.08 
P<0.0001* 
Study 90 31.47±39.89 
Association between the Serum homocysteine level in study group with 
Age 
<60 32 27.48±35.14 
P=0.4281NS 
≥60 58 33.65±42.43 
Gender 
Male 60 29.18±37.47 
P=0.4739NS 
Female 30 36.02±44.67 
DiabetesMellitus 
Yes 19 19.97±33.47 
P=0.0078* 
No 71 34.53±41.11 
Hypertension 
Yes 22 62.21±52.9 
P=0.0001* 
NO 68 21.51±28.75 
Smoking 
Yes 27 72.06±53.9 
P=0.0001* 
No 63 14.06±06.13 
Diagnosis 
Infarct 77 31.38±39.77 
P=0.5817NS 
Hemorrhage 13 31.92±42.26 
Table1. Comparison of serum homocysteine level and its association with study group  
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several possible mechanisms have been proposed [11]. 
Hyperhomocysteinemia is associated with premature 
atherosclerosis. 
Experimental studies both in vivo and in vitro shows 
that homocysteine causes endothelial injury and cell 
detachment. Hence these data suggest that homocys-
teine might contribute to cerebrovascular disease in 
patients as an additive risk factor [12].  Measure-
ment of homocysteine may become the integral part of 
workup of stroke patients in future. 
CONCLUSION 
In conclusion the present study revealed that hyperho-
mocysteinemia appears to be an important risk factor 
for cerebrovascular accidents. It is therefore important 
to use serum homocysteine level as an important tool 
to investigate all cases of cerebrovascular accidents 
and also in those who are at risk of developing stroke. 
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